Wells Fargo’s Minerva Surgical, Inc. Common Stock UTRS Stock Holding History

Wells Fargo’s Portfolio UTRS Stock Details UTRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7	Closed	-$21	–	7841
2023 Q3	$21	Sell	7 -1	-13%	-$5	﹤0.01%	7191
2023 Q2	$39	Buy	8 +1	+14%	+$5	﹤0.01%	7122
2023 Q1	$32	Buy	7 +4	+133%	+$25	﹤0.01%	7240
2022 Q4	$13	Hold	3	–	–	﹤0.01%	7359
2022 Q3	$0	Buy	3 +1	+50%	+$38	﹤0.01%	7695
2022 Q2	$0	Hold	2	–	–	﹤0.01%	7801
2022 Q1	$0	Hold	2	–	–	﹤0.01%	8131
2021 Q4	$0	Buy	+2	New	+$284	﹤0.01%	8067

Wells Fargo's UTRS Position: Q4 2023 in Review

Wells Fargo sold out of Minerva Surgical, Inc. Common Stock (UTRS) in Q4 2023, closing a stake of 7 shares — an estimated $21 sold.

Wells Fargo first reported a position in UTRS in Q4 2021 and held it in 8 quarters. The position peaked at $39 in Q2 2023. 0 funds tracked by Wall St. Rank hold UTRS as of Q4 2023.

Wells Fargo reported no remaining Minerva Surgical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Wells Fargo sold 7 Minerva Surgical, Inc. Common Stock shares in Q4 2023, an estimated $21.
Wells Fargo first reported a position in Minerva Surgical, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
Wells Fargo's Minerva Surgical, Inc. Common Stock position peaked at $39 in Q2 2023.
0 funds tracked by Wall St. Rank held Minerva Surgical, Inc. Common Stock as of Q4 2023.

Based on Wells Fargo's 13F filing for Q4 2023, filed 9 Feb 2024.